Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

Authors :: SUCIU S.
MANDELLI F.
DE WITTE T.
ZITTOUN R.
GALLO E.
LABAR B.
BELHABRI A.
GIUSTOLISI R.
DELARUE R.
LISO V.
BOURHIS J.H.
DE ROSA, GENNARO
Suciu, S.
Mandelli, F.
DE WITTE, T.
Zittoun, R.
Gallo, E.
Labar, B.
DE ROSA, Gennaro
Belhabri, A.
Giustolisi, R.
Delarue, R.
Liso, V.
Bourhis, J. H.
Publication Year :: 2003
Publisher :: American Society of Hematology:1900 M Street Northwest, Suite 200:Washington, DC 20036:(800)633-4931, (202)776-0544, EMAIL: publishing@hematology.org, ash@hematology.org, INTERNET: http://www.hematology.org, Fax: (202)776-0551, 2003.

Tools